Literature DB >> 21394064

Assessment of gelatinase and tumor necrosis factor-α level in the vitreous and serum of patients with Eales disease: role of inflammation-mediated angiogenesis in the pathogenesis of Eales disease.

Aditi Sen1, Suman K Paine, Imran H Chowdhury, Amrita Mukherjee, Subhadip Choudhury, Lakshmi K Mandal, Basudev Bhattacharya.   

Abstract

BACKGROUND: Eales disease (ED) is an idiopathic, inflammatory, venoocclusive disorder of peripheral retina resulting in retinal angiogenesis and vitreous hemorrhage. The objective of the present study is to investigate the expression and activation of gelatinase associated with the retinal neovascularization in ED and the relation between the levels of gelatinase and the cytokine tumor necrosis factor-α, known to upregulate matrix metalloproteinase (MMP) expression on various cells.
METHODS: Vitreous and serum samples from 19 patients with ED who underwent retinal surgery were estimated for levels of MMP-2, MMP-9, tissue inhibitor of metalloproteinase-1, tissue inhibitor of metalloproteinase-2, and tumor necrosis factor-α by enzyme-linked immunosorbent assay method. Matrix metalloproteinase-2 and MMP-9 activities in serum and vitreous samples were evaluated by gelatin zymography method. Vitreous samples from 16 patients with macular hole undergoing vitrectomy were used as controls.
RESULTS: Among the 2 gelatinase examined in vitreous and serum samples, only level and activity of MMP-9 were significantly higher in serum (P = 0.0001) and vitreous (P = 0.0002) samples of patients with ED than those of control subjects. Simultaneously, a positive correlation was found between intraocular tumor necrosis factor-α and MMP-9 concentration (Spearman correlation coefficient, r = 0.7040, P = 0.0023) in patients with ED.
CONCLUSION: Increase in MMP-9 activity and its concentration in serum and vitreous of patients with ED compared with that of control subjects and correlation between intraocular levels of MMP-9 and tumor necrosis factor-α in patients with ED seem to provide a plausible explanation for inflammation-mediated angiogenesis during the development of this condition.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21394064     DOI: 10.1097/IAE.0b013e318203c199

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  6 in total

1.  Protein-ligand interaction studies of retinol-binding protein 3 with herbal molecules using AutoDock for the management of Eales' disease.

Authors:  Anshul Tiwari; Sandeep Saxena; A B Pant; Prachi Srivastava
Journal:  J Ocul Biol Dis Infor       Date:  2012-12-30

2.  Comparative modeling of retinol-binding protein-3 and retinal S-antigen in Eales' disease and prediction of their binding sites using computational methods.

Authors:  Anshul Tiwari; Ashish Chandra Trivedi; Prachi Srivastava; Aditya Bhusan Pant; Sandeep Saxena
Journal:  J Ocul Biol Dis Infor       Date:  2011-07-26

Review 3.  The unfolded protein response in retinal vascular diseases: implications and therapeutic potential beyond protein folding.

Authors:  Sarah X Zhang; Jacey H Ma; Maulasri Bhatta; Steven J Fliesler; Joshua J Wang
Journal:  Prog Retin Eye Res       Date:  2014-12-18       Impact factor: 21.198

4.  Comparisons of Vitreal Angiogenic, Inflammatory, Profibrotic Cytokines, and Chemokines Profile between Patients with Epiretinal Membrane and Macular Hole.

Authors:  Lu Chen; Weiwei Zhang; Ping Xie; Jiangdong Ji; Huiming Qian; Songtao Yuan; Qinghuai Liu; Zizhong Hu
Journal:  J Ophthalmol       Date:  2021-07-13       Impact factor: 1.909

5.  Eales' disease - current concepts in diagnosis and management.

Authors:  Jyotirmay Biswas; Reesha Karingattil Ravi; Angayarkanni Naryanasamy; Lily Therese Kulandai; Hajib Naraharirao Madhavan
Journal:  J Ophthalmic Inflamm Infect       Date:  2013-01-14

6.  Eales disease in a young adult man Case report.

Authors:  Dan Călugăru; Mihai Călugăru; Chabi El Ghali
Journal:  Rom J Ophthalmol       Date:  2017 Oct-Dec
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.